These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9212888)
1. Accumulation of 99mTc-HMPAO and 99mTc-ECD in rodent and human breast tumor cell lines in vitro. Ballinger JR; Duncan J; Hua HA; Ichise M Ann Nucl Med; 1997 May; 11(2):95-9. PubMed ID: 9212888 [TBL] [Abstract][Full Text] [Related]
2. [A case of meningioma with non-accumulation of 99mTc-ECD and increased accumulation of 99mTc-HMPAO in the tumor]. Kashimada A; Machida K; Honda N; Mamiya T; Takahashi T; Kamano T; Muramatsu M; Inoue Y Kaku Igaku; 1992 Sep; 29(9):1127-31. PubMed ID: 1453563 [TBL] [Abstract][Full Text] [Related]
3. Different uptake of 99mTc-ECD adn 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping. Hyun Y; Lee JS; Rha JH; Lee IK; Ha CK; Lee DS Eur J Nucl Med; 2001 Feb; 28(2):191-7. PubMed ID: 11303889 [TBL] [Abstract][Full Text] [Related]
4. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. Léveillé J; Demonceau G; Walovitch RC J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328 [TBL] [Abstract][Full Text] [Related]
5. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe. Oku N; Matsumoto M; Hashikawa K; Moriwaki H; Ishida M; Seike Y; Terakawa H; Watanabe Y; Uehara T; Nishimura T J Nucl Med; 1997 Jul; 38(7):1109-11. PubMed ID: 9225799 [TBL] [Abstract][Full Text] [Related]
6. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168 [TBL] [Abstract][Full Text] [Related]
7. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO]. Makino K; Masuda Y; Gotoh S Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624 [TBL] [Abstract][Full Text] [Related]
8. Dissociation of 99mTc-ECD and 99mTc-HMPAO distributions in herpes simplex encephalitis. Tohyama Y; Sako K; Daita G; Yonemasu Y; Shuke N; Aburano T Childs Nerv Syst; 1997 Jun; 13(6):352-5. PubMed ID: 9272290 [TBL] [Abstract][Full Text] [Related]
9. 99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease. Koulibaly PM; Nobili F; Migneco O; Vitali P; Robert PH; Girtler N; Darcourt J; Rodriguez G Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1009-13. PubMed ID: 12750851 [TBL] [Abstract][Full Text] [Related]
10. [A comparative study of the quality of SPECT images obtained by 123I-IMP, 99mTc-HMPAO and 99mTc-ECD]. Odano I; Ohkubo M; Takahashi M; Noguchi E; Ohtaki H; Kasahara T; Shibaki M; Hatano M Kaku Igaku; 1997 Mar; 34(3):189-94. PubMed ID: 9136527 [TBL] [Abstract][Full Text] [Related]
11. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults. Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088 [TBL] [Abstract][Full Text] [Related]
12. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison. Asenbaum S; Brücke T; Pirker W; Pietrzyk U; Podreka I J Nucl Med; 1998 Apr; 39(4):613-8. PubMed ID: 9544665 [TBL] [Abstract][Full Text] [Related]
13. Oxido-reductive state: the major determinant for cellular retention of technetium-99m-HMPAO. Jacquier-Sarlin MR; Polla BS; Slosman DO J Nucl Med; 1996 Aug; 37(8):1413-6. PubMed ID: 8708786 [TBL] [Abstract][Full Text] [Related]
14. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease. Nobili F; Koulibaly PM; Rodriguez G; Benoit M; Girtler N; Robert PH; Brugnolo A; Darcourt J Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817 [TBL] [Abstract][Full Text] [Related]
15. SPECT image analysis using statistical parametric mapping: comparison of technetium-99m-HMPAO and technetium-99m-ECD. Patterson JC; Early TS; Martin A; Walker MZ; Russell JM; Villanueva-Meyer H J Nucl Med; 1997 Nov; 38(11):1721-5. PubMed ID: 9374340 [TBL] [Abstract][Full Text] [Related]
16. Quantitative comparison between 99mTc-HMPAO and 99mTc-ECD: measurement of arterial input and brain retention. Pupi A; Castagnoli A; De Cristofaro MT; Bacciottini L; Petti AR Eur J Nucl Med; 1994 Feb; 21(2):124-30. PubMed ID: 8162935 [TBL] [Abstract][Full Text] [Related]
17. An alternative approach to estimation of the brain perfusion index for measurement of cerebral blood flow using technetium-99m compounds. Murase K; Inoue T; Fujioka H; Ishimaru Y; Akamune A; Yamamoto Y; Mochizuki T; Ikezoe J Eur J Nucl Med; 1999 Oct; 26(10):1333-9. PubMed ID: 10541833 [TBL] [Abstract][Full Text] [Related]
18. Discrepancies in brain perfusion SPECT findings between Tc-99m HMPAO and Tc-99m ECD: evaluation using dynamic SPECT in patients with hyperemia. Miyazawa N; Koizumi K; Mitsuka S; Nukui H Clin Nucl Med; 1998 Oct; 23(10):686-90. PubMed ID: 9790044 [TBL] [Abstract][Full Text] [Related]
19. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. Koyama M; Kawashima R; Ito H; Ono S; Sato K; Goto R; Kinomura S; Yoshioka S; Sato T; Fukuda H J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207 [TBL] [Abstract][Full Text] [Related]
20. Discrepant 99mTc-ECD images of CBF in patients with subacute cerebral infarction: a comparison of CBF, CMRO2 and 99mTc-HMPAO imaging. Shishido F; Uemura K; Inugami A; Ogawa T; Fujita H; Shimosegawa E; Nagata K Ann Nucl Med; 1995 Aug; 9(3):161-6. PubMed ID: 8534592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]